A Hong Kong-based robotics manufacturer is moving to scale up production of humanoid robots, aiming to deliver thousands of units within 2021. Hanson Robotics, known globally for its lifelike robot Sophia, announced that four distinct humanoid models will begin leaving its production lines in the first half of the year. Sophia, which has garnered international attention for its human-like appearance and conversational abilities, remains central to the company’s expansion strategy.
Founder and CEO David Hanson stated to Reuters that the COVID-19 pandemic has intensified the need for automation capable of assisting and interacting with people. “The world of COVID-19 is going to need more and more automation to keep people safe,” he said. Historically, many of the company’s robots were assembled by hand, but the firm is now broadening its manufacturing capabilities to meet rising demand.
At present, there are 24 versions of Sophia, serving as a platform for developing “many other kinds” of models. While Hanson did not specify exact figures, he confirmed the company’s goal to sell “thousands” of robots by year’s end. The initial focus is on deploying these humanoids in healthcare environments, where they can perform tasks such as temperature screening to detect potential illness or leading physical exercise routines for elderly individuals.
These social robots integrate machine learning algorithms and artificial intelligence to interpret human faces, gestures, and activities through embedded cameras and sensors. Over time, they are designed to cultivate a degree of social and emotional intelligence, enabling more natural and supportive interactions. During a laboratory demonstration, a Sophia unit articulated its potential role: “Social robots like me can help take care of the sick or elderly in many kinds of healthcare and medical uses.”
Hanson envisions applications beyond healthcare. He noted that the humanoids’ human-like form and behavior make them suitable for public-facing roles in retail and airline services. “They can be so useful during these times where people are terribly lonely and socially isolated,” he said. “I can help communicate, give therapy and provide social stimulation, even in difficult situations.”
Johan Hoorn, a social robotics professor at Hong Kong’s Polytechnic University who has collaborated on Sophia’s development, observed that the pandemic may accelerate the integration of robots into daily life. “I can infer the pandemic will actually help us get robots earlier in the market because people (will) start to realize that there is no other way,” Hoorn said.
The trend is not isolated to Hanson Robotics. SoftBank Robotics’ humanoid robot Pepper has been deployed in Europe to identify individuals without face coverings, demonstrating how robots can enforce public health measures. In China, CloudMinds contributed to the creation of a robot-operated field hospital in Wuhan for COVID-19 patients, underscoring the role of robotics in emergency healthcare infrastructure.
The International Federation of Robotics reported a significant uptick in professional-service robot sales even before the pandemic, with a 32 percent increase from 2018 to 2019. This growth reflects broader advances in robotics technology, including improvements in sensor integration, actuator precision, and AI-driven decision-making. For engineers and enthusiasts, the shift from hand-built prototypes to scalable manufacturing marks a critical juncture, enabling wider deployment and more diverse use cases.
In the context of mechanical design, humanoid robots like Sophia combine complex mechatronic systems with adaptive software architectures. The mechanical framework must balance anthropomorphic aesthetics with functional durability, while the embedded control systems coordinate multiple degrees of freedom for expressive movement. These design challenges are compounded by the need for robust, real-time perception, requiring efficient processing pipelines to handle multimodal sensory input.
As production ramps up, the interplay between hardware engineering and AI development will determine the robots’ effectiveness in real-world environments. For the robotics sector, Hanson Robotics’ initiative illustrates how global health crises can catalyze both technological innovation and market adoption, pushing humanoid systems from research labs into everyday service roles.